Health and Medicine

Set to take place at The Venetian Expo in Las Vegas, the Expo will run from September 18-21, 2024, and is expected to attract thousands of eye care professionals, ophthalmic experts, and industry innovators. The event's comprehensive educational program, VisionEd, including OptiCon @ Vision Expo, will commence Wednesday, September 18, the day before the exhibit hall opening. Much like its counterpart Vision Expo East, the West edition aims to deliver an outstanding and comprehensive event that brings together everything from the industry's leading continuing education offering of accredited optometric, opticianry, and business education programs, led by world-renowned experts, to the…

The Napa Primary Care Conference is a unique educational conference for physicians and medical professionals who care for active and athletic patients or who themselves lead such a lifestyle. 16 HOURS AAFP CME CREDIT Location The conference will be held at The Napa Valley Marriott Resort and Spa, conveniently located within minutes of renowned wineries, shopping, attractions, and numerous options for exercise and physical activity. Course Description This conference will present very practical information that you can use in your practice. Topics will include common medical and musculoskeletal problems that affect patients who lead an active lifestyle. The focus will…

The 5th Genome Editing Therapeutics Summit (formerly CRISPR 2.0) is the industry's foremost meeting for spearheading the development, application, and delivery of novel gene editing technologies in the therapeutic setting. Data-driven talks, expert panel discussions, and interactive group discussions will cover the therapeutic application and drug development challenges of both: 1. More established technologies, and their associated translational, nonclinical, clinical, and strategic challenges: including novel nucleases, base, prime, and multiplex editing techniques 2. Ground-breaking precision tools enabling small and large alterations to the genome, including epigenome editing, recombinase and transposon-based technologies, and novel delivery vehicles Across three days, industry and…

Liquid biopsies are revolutionizing clinical trials, emerging as a game-changing diagnostic tool for monitoring molecular residual disease and detecting disease resistance. This breakthrough enables precise patient stratification, ensuring they receive the most effective and safe treatments. In 2024, a wave of collaborations has surged, propelling the use of liquid biopsies for MRD testing to new heights. The FDA's recognition of MRD as an endpoint in multiple myeloma marks a monumental leap forward for the field, heralding a new era in patient care and therapeutic development. The 3rd Liquid Biopsy Surveillance Summit returns as the leading East Coast forum solely dedicated…

Join the 10th World Congress on Neurology and Therapeutics in Dubai, Nov 21-22, 2024. Showcase your research, network with experts, and explore the latest innovations in the field.

Achieving Efficacy and Exploring Indication Expansion for Complement Inhibitors The complement community is shifting gear, with more companies than ever targeting alternative complement proteins for their therapies, allowing for a larger range of diseases to be targeted. With more assets in ophthalmology, neurology, and oncology than ever before, the complement-based therapeutics field has everyone asking the same question: which inhibitor will be the next to harness the complement system for the development of groundbreaking therapies? From the discovery of new pathways to target to post-approval indication expansion, the immunology landscape is primed to capitalize on the huge strides being taken…

Aloha! Join us for Primary Care Hawaii July 21-25, 2025 at the fabulous Grand Hyatt Kauai Resort and Spa on the Garden Isle of Kauai, Hawaii. Primary Care Hawaii is a unique educational conference for physicians and medical professionals who care for active and athletic patients or who themselves lead such a lifestyle. This conference will present very practical information that you can use in your practice. Topics will include common medical and musculoskeletal problems that affect patients who lead an active lifestyle. The focus will be on providing information that will help you diagnose and manage these conditions in…

Precision healthcare in the Asia-Pacific region has seen a surge in advancements within the last 12 months; including NGS and laboratory-based tests, approvals (like a companion diagnostic test for lung cancer), and evolving regulations. The World Companion Diagnostics and Liquid Biopsy Summit APAC provides an opportunity to unite with your fellow biopharma, diagnostic providers and leading academics to navigate liquid biopsy and companion diagnostic testing and ensure precision therapies become accessible to all patients. Join 100+ of your colleagues working within Precision Medicine, Companion Diagnostics, Medical Affairs and Commercialization from China, Japan, Australia, Singapore and more to accelerate the co-development…

Fortunately, new developments occur rapidly in all involved disciplines. New Gastroenterology techniques lead to earlier detection and better endoscopic treatment. New Radiology features lead to better staging, whereas new Surgical techniques, like sentinel node, laparoscopic and robot-assisted procedures, lead to less invasive operations and quicker recovery. New Pathology techniques lead to a better definition of each tumor and give rise to targeted and other systemic therapies. Furthermore, radiation therapies improve and are applied pre- and post-operatively and for palliative settings. Due to the international character of the congress, different views and experiences can be shared and can easily lead to…

In the dynamic landscape of cell therapy development, Asia is emerging as a powerhouse, witnessing a remarkable surge in investment and receiving strong regulatory support as companies rapidly progress in clinical and commercial development. Against this backdrop of rapid progress, the 3rd CAR-TCR: Cell Therapy Summit Asia stands as the pivotal gathering for industry players across the APAC region looking to capitalize on Asia's cell therapy boom. URL: Tickets: https://go.evvnt.com/2612151-2?pid=154 Time: 9:00 AM - 6:00 PM Prices: Academic Pricing - Conference Only: USD 0.50, Industry Pricing - Conference Only: USD 0.50, Service Provider Pricing - Conference Only: USD 3699.00 Speakers:…

CONy is an annual meeting that offers a unique platform for global experts to debate and discuss the most pressing and controversial issues in neurology. The Congress aims to provide the most recent data armoring the clinician with reliable, up-to-date scientific information, helping in everyday patient care. The unique debate-style structure encourages active participation from attendees through engaging discussions and debate voting, fostering collaborative learning and knowledge dissemination within the neurological field. From insightful sessions to unparalleled networking opportunities the event is a treasure trove of knowledge and inspiration. URLs: Tickets: https://go.evvnt.com/2614409-0?pid=154 Facebook: https://go.evvnt.com/2614409-2?pid=154 LinkedIn: https://go.evvnt.com/2614409-3?pid=154 Time: 8:00 AM -…

Madrigal's blockbuster drug gaining FDA approval this March has opened the doors to a wave of therapeutics from Eli Lilly, Boehringer Ingelheim, AstraZeneca, Amgen, Akero Therapeutics and more that hold huge promise in Phase 1, 2, and 3 clinical trials. Paired with the boom of GLP-1s, these milestones have reinvigorated investment throughout the metabolic space. The 8th MASH Drug Development Summit is the perfect forum to unite and discuss the evolving drug development opportunity for MASH and metabolic diseases. From optimizing clinical trial design to overcoming regulatory challenges, combatting fibrosis, navigating GLP-1 usage, optimizing RWE integration and achieving accurate non-invasive…

Target audience The educational course is intended for physicians, residents, nurses, physician assistants, and all other health professionals involved in treating burn care patients. Insurance In registering for EBA 2024, delegates agree that neither the organization nor the congress agency Congress Care is responsible for individual medical, travel, or personal insurance. Delegates are requested to make their own travel and health insurance. The organizers cannot assume liability for changes in the program due to external circumstances. Accreditation for the 3rd Educational Course CME accreditation for the European Burns Association Educational course will be requested by the European Accreditation Council for…

With the applications of LNPs rapidly expanding beyond vaccines, as well as beyond the liver, it is of utmost importance to predict and minimize adverse reactions to guarantee patient safety in the clinic, especially following a clinical hold on Verve Therapeutics' gene therapy earlier this year, due to safety concerns surrounding the LNP delivery system. Returning in December, the 3rd LNP Immunogenicity and Toxicity Summit will return as your unique forum uniting industry experts striving to measure, predict and monitor non-clinical and clinical safety risk for lipid nanoparticles to ensure regulatory compliance for vaccines, gene and cell therapies. Join experts…

With 5% of cancer drugs going into the clinic, it is critical that oncology scientists invest in more translational and predictive models to de-risk the validation of novel targets, predict therapeutic response, and support biomarker discovery, particularly with such a high price tag for clinical failure. The 13th Tumour Models London Summit stands as the only industry-led meeting uniting pharma, biotech, and preclinical CROs from Europe to network and discuss new trends and innovations in tumour models. Attracting leading preclinical and translational expertise, this forum provides an essential platform for scientists and decision makers to hear about the latest innovations…

The Complex Bioengineering for Cell Therapies Summit is the premier event for bioengineering experts. Explore cutting-edge technologies and platforms driving the next generation of cell therapies, with a unique focus on the intricate molecular biology of the TME and advanced design and delivery technologies. With increasing FDA scrutiny on CAR-T therapies and challenges with solid tumors, this event is timely and essential. Connect with top experts from A2 Biotherapeutics, Bristol Myers Squibb, Senti Biosciences, and more. Engage in strategic discussions and see technology showcases that will drive your cell therapy products forward. This November is your opportunity to lead in…

Current knowledge, tools and practices will not be enough to achieve equitable coverage goals, which is why AI2030 strategic priorities focus on improving global and national research capacities.and innovationto increase equitable vaccination coverage, extend the benefits of vaccination to other populations, identify and respond to unmet needs and emerging challenges. The strategic priorities of IA2030 highlight specific research and innovation needs for vaccination programs but also the PHC platform, with a view to the integration continuum. Thus, GaneshAID and its partners wish, through the initiative KLIC (Knowledge Lab for Innovation Community), participate in responding to these research and innovation needs

Join us for 16th Annual Congress on Controversies in Ophthalmology (COPHy) which will take place on April 4-5, 2025 in Seville, the captivating capital of Andalusia, Spain renowned for its beautiful architecture and rich culture. COPHy 2025 will continue to focus on the debates concerning controversial issues in ophthalmology, the core of the congress. Leading world experts will present two opposed approaches to controversial issues. Each topic presented will be followed by a live discussion of ophthalmologists experienced in the area being discussed. For more information contact: https://cophy.comtecmed.com/ URLs: Tickets: https://go.evvnt.com/2607727-0?pid=154 Facebook: https://go.evvnt.com/2607727-2?pid=154 LinkedIn: https://go.evvnt.com/2607727-3?pid=154 Time: 8:00 AM - 7:00…

The meeting is hosted by the local organizing committee from the University Heart and Vascular Center Hamburg, Clinic for Children’s Heart Medicine and Adults with Congenital Heart Disease. The AEPC 2025 Annual Meeting will be held in the Congress Center Hamburg (CCH), which is one of Europe's top convention centers and is conveniently located downtown. We strive to provide an exciting annual meeting. We look forward to hosting an academically engaging conference with exceptional speakers on important topics in congenital heart disease. We have established a local scientific committee that works closely with the AEPC Scientific Advisory Group to ensure…

In light of Anavex's announcement of its first entire clinical gene pathway data in patients with Rett syndrome, coupled with Mission Therapeutics' recent fundraising of £25.2 million to progress the clinical development of its lead drug candidates, there has been increasing evidence of interest taking place towards broader disease groups with underlying pathogenesis from mitochondrial dysfunction. This November, we will unite 60+ C-Level, Biologist, Preclinical, Translational, and Innovation-Scouting Leaders who are building on from the industry's latest setbacks to innovate mitochondrial-targeting approaches and expand novel therapeutic opportunities. From cutting-edge research backed by academia to transformative pipeline updates from preclinical and…